Current Open Proposals
Early Phase Drug Development Support Program
Proposal Due Date: February 27, 2026 at 5pm
Submit Proposal to: rspitale@uci.edu
Summary Background (full details found in attachment):
The UCI Center for Neurotherapeutics (UCI CNT) is pleased to announce a call for applications focused on the discovery and development of small molecules intended to therapeutically modulate targets or pathways implicated in neurological diseases (i.e. any disorder affecting the brain, spinal cord, neuromuscular system, or retina, including neuropsychiatric disorders). Applications will be selected for entry into the UCI CNT’s Drug Discovery unit, which consists of three distinct, complementary service cores:
a) High-throughput assay development/ DNA-encoded library selection
b) Computational chemistry
c) Medicinal “hit-to-lead”
Previous Proposals
Enhancing CNS Delivery of Therapeutic Agents
Proposal Due Date: February 2, 2024 at 5pm
Early Phase Drug Development Support Program
Proposal Due Date: February 2, 2024 at 5pm